One study (NCT04640324) aimed to explore the effect of the silybin-phospholipid complex, vitamin D, and vitamin E in NAFLD patients carrying PNPLA3 rs738409, TM6SF2 rs58542926, and Membrane Bound O-Acyltransferase-Domain-Containing 7 (MBOAT7) rs641738 genetic variants. The gene discussed is TM6SF2; the disease is metabolic dysfunction-associated steatotic liver disease.